*Prices reflect U.S. average retail price
Carbamazepine (CBZ), sold under the tradename Tegretol among others, is a medication used primarily in the treatment of epilepsy and neuropathic pain. It is not effective for absence seizures or myoclonic seizures. It is used in schizophrenia along with other medications and as a second line agent in bipolar disorder. Carbamazepine appears to work as well as phenytoin and valproate... Wikipedia
Manufacturer's Website: Not Available Average retail cost: $150/month
Carbamazepine (CBZ), sold under the tradename Tegretol among others, is a medication used primarily in the treatment of epilepsy and neuropathic pain. It is not effective for absence seizures or myoclonic seizures. It is used in schizophrenia along with other medications and as a second line agent in bipolar disorder. Carbamazepine appears to work as well as phenytoin and valproate... Wikipedia
Manufacturer's Website: Not Available Average retail cost: $229/month
Carbamazepine (CBZ), sold under the tradename Tegretol among others, is a medication used primarily in the treatment of epilepsy and neuropathic pain. It is not effective for absence seizures or myoclonic seizures. It is used in schizophrenia along with other medications and as a second line agent in bipolar disorder. Carbamazepine appears to work as well as phenytoin and valproate... Wikipedia
Manufacturer's Website: Not Available Average retail cost: $196/month
Carbamazepine (CBZ), sold under the tradename Tegretol among others, is a medication used primarily in the treatment of epilepsy and neuropathic pain. It is not effective for absence seizures or myoclonic seizures. It is used in schizophrenia along with other medications and as a second line agent in bipolar disorder. Carbamazepine appears to work as well as phenytoin and valproate... Wikipedia
Manufacturer's Website: Equetro Average retail cost: $232/month
Oxcarbazepine is an anticonvulsant drug primarily used in the treatment of epilepsy. There is some evidence for oxcarbazepine as a mood-stabilizing agent and thus, it can be used as add-on therapy for bipolar disorder in patients that have failed or are unable to tolerate approved treatments... Wikipedia
Manufacturer's Website: Oxtellar XR Average retail cost: $166/month
Oxcarbazepine is an anticonvulsant drug primarily used in the treatment of epilepsy. There is some evidence for oxcarbazepine as a mood-stabilizing agent and thus, it can be used as add-on therapy for bipolar disorder in patients that have failed or are unable to tolerate approved treatments... Wikipedia
Manufacturer's Website: Not Available Average retail cost: $784/month
Eslicarbazepine acetate (trade names Aptiom in North America, Zebinix in Europe, Exalief in Russia), abbreviated as ESL, is an anticonvulsant medication approved for use in Europe and the United States as monotherapy or adjunctive therapy (additional therapy) for partial-onset seizures epilepsy... Wikipedia
Manufacturer's Website: Aptiom Average retail cost: $1,352/month
Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders. Rufinamide, a triazole derivative, was developed in 2004 by Novartis Pharma, AG, and is manufactured by Eisai... Wikipedia
Manufacturer's Website: Banzel Average retail cost: $5,439month